Galux
Seoul, Seoul, South Korea · Artificial Intelligence, Biotechnology
Galux is a South Korean biotech company that specializes in AI-driven protein therapeutics discovery. The company is focused on developing innovative solutions for precise protein design in therapeutic applications. Its advanced AI platforms aim to tackle challenges in molecular design and optimize the development of targeted therapies.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Seoul, Seoul, South Korea
- Employees
- Unknown
- Industries
- Artificial Intelligence, Biotechnology
- Status
- Private
- Website
- galux.co.kr
- Company page
Recent activity at Galux
- : Galux Appoints Park Tae-yong as New Chief Executive Officer
- : Galux Raises $29M Series B to Advance AI-Driven Protein Design for Drug Discovery. This funding will enhance its AI platform and drug discovery capabilities.
- : Galux Signs Research Agreement with Boehringer Ingelheim to Enhance AI-Driven Protein Design.
About Galux: questions and answers
What does Galux do?
Galux is a South Korean biotech company that specializes in AI-driven protein therapeutics discovery. The company is focused on developing innovative solutions for precise protein design in therapeutic applications. Its advanced AI platforms aim to tackle challenges in molecular design and optimize the development of targeted therapies.
Where is Galux headquartered?
Galux is headquartered in Seoul, Seoul, South Korea.
What is the latest news on Galux?
On Jul 28, 2026, Galux Appoints Park Tae-yong as New Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy